Skip to content

May 1, 2026

Home
Signal News
Biopharma Brief
Week in Review
Contact

Light/Dark Button

Search for:

Home
M&A / Deals
Parexel buys Vitrana to boost patient safety toolkit

M&A / Deals

Parexel buys Vitrana to boost patient safety toolkit

Pharmaphorum

Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed sum.

Read full story

pharminent April 30, 2026 (Last updated: May 1, 2026)

Pharmaphorum

Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed sum.

Read full story

Post navigation

Previous: UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy

Next: Merck still sees ‘compelling’ outlook for Terns leukemia drug

Related Stories

M&A / Deals

LEO Pharma to acquire gene therapy company Replay

pharminent May 1, 2026

M&A / Deals

Two biotechs raise a combined $556M in latest spurt of IPOs

pharminent May 1, 2026

M&A / Deals

Teva makes its first M&A play in years, buying Emalex

pharminent April 30, 2026

You May Have Missed

Manufacturing

Novartis unveils North Carolina API plant as final piece of $23B US expansion

pharminent May 1, 2026

Pipeline

Amgen positions MariTide as potential ‘best monthly’ obesity drug

pharminent May 1, 2026

Regulatory

FDA’s ODAC delivers one loss, one win for AstraZeneca

pharminent May 1, 2026

Regulatory

Axsome receives FDA approval for Auvelity to treat Alzheimer’s agitation

pharminent May 1, 2026

Copyright © 2026 All rights reserved. | ReviewNews by AF themes.